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Introduction
Deposition of Iron in brain causes a spectrum of disorders characterized by 
a progressive neurodegeneration and extrapyramidal symptoms. This brain 
Iron accumulation was first reported by Julius Hallervorden and Hugo Spatz, 
German neuropathologist, who conducted studies on brain specimens of mentally 
handicapped persons, executed during third Reich euthanasia program in the context 
of “Racial Hygiene”(1).
Today, this Iron deposition is easily diagnosed by magnetic resonance imaging 
techniques (figure 1). The classic form of Hallervorden-Spatz syndrome consisted 
of progressive gait and postural difficulties since early childhood. This was followed 
by other extra pyramidal signs like Parkinsonism and also cognitive decline 
characterized by behavioral changes and dementia (2). When a novel Pantothenate 
Kinase gene (PANK2) was identified as being defective inHallervorden-Spatz 
syndrome, and regarding serious ethical issues in the scientific activities of the two 
German neuropathologist, a new nomenclature was suggested. So this syndrome 
was named Pantothenate-Kinase associated neurodegeneration (PKAN). However, 
recent advances in brain MRI modalities and genetic linkage techniques led us to 
recognitionof broader spectrum phenotypes in a group of syndromes having in 
common: Iron accumulation in the brain, mainly in basal ganglia (preferentially 
the globus pallidus) and a clinical neurodegenerative course with prominent extra 
pyramidal symptoms. These are named syndromes of Neurodegeneration with 
Brain Iron Accumulation (NBIA) (3).
Abstract
Objective 
Neurodegeneration with brain iron accumulation (NBIA) is a group of 
neurodegenerative disorder with deposition of iron in the brain (mainly Basal 
Ganglia) leading to a progressive Parkinsonism, spasticity, dystonia, retinal 
degeneration, optic atrophy often accompanied by psychiatric manifestations 
and cognitive decline. 8 of the 10 genetically defined NBIA types are inherited 
as autosomal recessive and the remaining two by autosomal dominant and 
X-linked dominant manner. Brain MRI findings are almost specific and show 
abnormal brain iron deposition in basal ganglia some other related anatomical 
locations. In some types of NBIA cerebellar atrophy is the major finding in MRI. 
Keywords: Pantothenate Kinase Associated Neurodegeneration; 
Neurodegeneration With Brain Iron Accumulation; Hallervorden- Spatz 
syndrome; Neuroaxonal Dystrophy
Neurodegeneration with Brain Iron Accumulation: An Overview
How to Cite This Article: Tonekaboni SH, Mollamohammadi M. Neurodegeneration with Brain Iron Accumulation: An Overview. Iran 
J Child Neurol. 2014 Autumn;8(4): 1-8.
2 Iran J Child Neurol. 2014 Autumn Vol 8 No 4 
 By now ten established genes, with their causative 
mutations, are known to cause different sub types of NBIA 
(table 1) (4). Although NBIA syndromes are rare genetic 
disorders with classic Mendelian inheritance (mostly 
autosomal Recessive type), some pathologic mutations 
in NBIA genes have been reported in rare monogenic 
Mendelian inheritance cases of Parkinson disease 
like ATP13A2 and PLA2G6 gene that are assigned 
respectively as PARK9 and PARK14 gene. Adding to 
this, demonstration of Lewy bodies and tau-positive 
tangles in brain specimens of NBIA cases (a pathologic 
finding in some adult onset sporadic neurodegenerative 
disease including Parkinson, Alzheimer and Fronto 
temporal dementia), shows an overlap between more 
common neurodegenerative disorders and some of the 
NBIA syndromes (5). There is also an overlap with other 
genetic diseases, once thought as being distinct conditions 
and usually not associated with Iron accumulation, as 
an example, mutations in FA2H gene lead to a FAHN 
phenotype (of NBIA group) while mutation in the same 
gene causes a form of hereditary spastic paraplegia 
(HSP) (6) and a leukodystrophy with spastic paraparesis 
and dystonia (7). Except aceruloplasminemia and 
neuroferritinopathy, mutations in other genes implicated 
in NBIA, are not directly involved in metabolic pathways 
of iron metabolism. Although demonstration of iron 
accumulation in the brain is essential for diagnosis of 
NBIA, however we still don’t know if iron deposition is 
the underlying key pathologic process in NBIA or if it is 
only an epiphenomenon of neurodegeneration.
NBIA is a clinicoradiological entity characterized by 
progressive neurological deterioration with prominent 
extrapyramidal symptoms, intellectual impairment 
and iron accumulation identified on brain MRI. There 
is significant phenotypic heterogeneity among NBIA 
syndromes and also an overlap with other genetic 
neurodegenerative disorders (spinocerebellar ataxia, 
Hereditary spastic paraplegia, Leukodystrophy, 
hereditary dystonia and mitochondrial disorder).
NBIA type 1: PKAN
Pantothenate Kinase-Associated Neurodegeneration 
(PKAN) is the most common and the most studied 
disorder of the NBIA group. In medical literature it 
was formerly known as Hallervorden-Spatz and also is 
the major component of the neuroaxonal dystrophies 
group. PKAN has variable phenotype which is mainly 
age dependent: the classic presentation has early onset 
and the atypical one (non-classic form) has later onset 
manifestation. 
In the classic form ataxia and postural difficulties start 
in early childhood. This is followed by progressive 
extra pyramidal symptoms: dystonia, chorea and 
Parkinsonism (2). Severe tongue protrusion dystonia is 
a prominent sign and along with limb dystonia causes 
severe disability in motor function within few years of 
disease onset (8). This motor regression is accompanied 
by cognitive decline and dementia. Impaired saccadic 
pursuit eye movements and disturbed vertical saccades 
(which is a major sign in Niemann-Pick C disease) 
herald mid-brain degeneration. Other ophthalmologic 
pathology consists of pigmentary retinopathy in 40% of 
patients, abnormal electroretinogram in two third and 
pupillary abnormalities (9). Pigmentary retinopathy is 
strongly in favor of PKAN and is absent in other forms 
of NBIA. But optic atrophy can also appear in FAHN, 
PLAN and MPAN.
 Atypical (late onset) PKAN’s are less common than 
classic form and mostly unrecognized regarding non-
specific neurologic presentations in adulthood. These 
symptoms consist of extrapyramidal complains like 
focal dystonia, unilateral tremor, retinopathy, cognitive 
deterioration, speech abnormality and psychiatric 
symptoms (for example palilalia) (3). Generally 
dyskinetic symptoms are milder in late onset patients 
when compared to classic PKAN and they remain 
ambulatory for decades. PKAN has a characteristic brain 
MRI pattern called “eye of the tiger sign” and consists 
of bilateral hyper intensity within surrounding hypo 
intensity in the globuspallidus in T2-weighted images. 
Pathologically there is a mild simultaneous involvement 
of substantia nigra pars reticulata, which may or may not 
appear on brain MRI. Practically, when such lesions are 
detected in T2-weighted images of a patient with clinical 
presentation compatible with PKAN, gradient-echo T2 
and susceptibility weighted imaging sequences should be 
reviewed to confirm iron accumulation. Other disorder 
showing signal changes of the basal ganglia such as 
organic acidemia, disorder of cofactor metabolism and 
mitochondropathies feature T2 hyper intensity rather 
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than hypo intensity (10). The eye of the tiger sign can be 
found in presymptomatic patients with PKAN and the 
central hyper intensity of the Globus pallidus can fade 
with disease progression, showing the dynamic nature of 
MRI findings in PKAN.
PKAN is an autosomal recessive disease with mutations 
detected in all seven exons of the PANK2 gene. 
Mutations are mostly missense; however duplication, 
deletion, splice-site mutation and exon deletion have 
also been reported (11, 12). It is still unresolved how 
mutation in PANK2 gene leads to iron accumulation. 
The protein encoded by PANK2 gene has a pivotal role 
in the metabolism of the vitamin B5 (pantothenate) (13). 
It has been hypothesized that lipids may be required for 
regulation of iron transport proteins and the alternation 
of ferroprotein expression, which is mediated by PANK2 
gene, may lead to iron brain deposition (14). Previous 
reports of Lewy body pathology and α-synuclein in 
PKAN (15,16) was before the identification of PANK2 
gene, and recent studies in genetically confirmed cases 
of PKAN contradict these results and no such pathology 
was found (17). Probably some of historical patients 
with Hallervorden-Spatz syndrome with α-synuclein 
accumulation and Lewy body pathology had not PKAN 
and they suffered from other NBIA.
NBIA type2: PLAN
Phospo-Lipase-Associated Neurolodegeneration(PLAN) 
is the second core of NBIA syndromes. Like PKAN 
there is age related phenotype variability with a clinical 
spectrum from infancy (early-onset) to adulthood 
(late-onset).in early onset cases affected children have 
progressive loss of cognitive and motor function. It is 
characterized by marked axial hypotonia, cerebellar 
ataxia, four limb spasticity, strabismus and bulbar 
dysfunction. Optic atrophy is a common finding and 
seizure disorder is noticed in some patients, although 
EEG changes as fast activity is a more frequent finding 
(18). Cerebellar cortical atrophy and gliosis is the most 
common finding in brain MRI. Late onset PLAN is 
characterized by a dystonia- Parkinsonism syndrome 
accompanied by pyramidal signs starting in adulthood. 
Abnormal eye movements, dementia and psychiatric 
manifestation may coexist. Parkinsonism is presented 
by tremor (pill rolling at rest), bradykinesia and rigidity 
with a favorable response to levodopa. In contrast to 
PKAN patients, Brain specimens in Plans show the 
alpha-synuclein-positive Lewy body pathology (19).
Cerebellar signs are less observed in late onset PLAN in 
contrast to dyskinesia which is a frequent finding. This 
fact is reinforced by the observation of cerebellar atrophy 
in early onset PLAN which is not a typical feature of the 
late onset form. Iron accumulation in Globus Pallidus 
causes hypointensity in MRI, but the “eye of the tiger 
sign” is not seen because of lack central hyperintensity. 
Brain MRI may be normal without any iron deposition, 
thus all patients with PLAN are not included in the larger 
group of NBIA.
Mutations PLA2G6 gene cause PLAN. This gene 
encodes the protein iPLA2 beta, which is involved 
in free fatty acids and lysophospholipidssynthesis. 
Disturbance of fatty acid metabolism can result in 
membrane trafficking dysregulation and in line with 
their accumulation, progressive neurologic deterioration 
supervene. PLA2G6 gene is a candidate gene for one 
form of monogenic Parkinson disease and has been 
assigned as ParK14 locus.
MPAN (Mitochondrial Protein Associated 
Neurodegeneration):
Mutation in the orphan gene C19orf12 (MMIN) is 
responsible for MPAN. Because of mitochondrial 
localization of tagged C19orf12 protein, dysfunction 
of fatty acids in the mitochondria is hypothesized as 
the pathologic mechanism of this disorder. C19orf12 
is located on chromosome 19q12 and is not part of 
mitochondrial genome. In the largest studied group in 
Poland, clinical manifestations started in childhood with 
speech and gait disturbance followed by pyramidal –
extrapyramidal signs, psychiatric symptoms and optic 
atrophy (20). Dystonia and prakinsonism were the 
major movement disorder observed in these patients. 
Iron accumulation was detected in Globus Pallidusand 
Substantia Nigra.
FAHN (Fatty Acid Hydroxylase-associated 
Neurodegeneration):
FAHN symptoms typically start in childhood with 
slowly progressive gait disturbance and focal dystonia in 
the legs and feet. Spastic quadriparesis, ataxia, dysarthria 
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and progressive visual loss due to optic atrophy develop 
later. Loss of cognitive function is reported in most of 
the patients and seizure disorder may be present in some. 
Neuroimaging reveals bilateral T2 hypointensity in 
Globus Pallidus, consistent with iron accumulation. 
White matter changes with or without brain stem and 
cerebellar atrophy increase gradually and may become 
profound. 
The disease is caused by mutation in Fatty acid-2 
Hydroxylase (FA2H) gene which is involved in lipid 
and ceramid metabolic pathway. Mutations in this gene 
are responsible for two other overlapping syndromes: 
one with leukodystrophy manifestations and the other 
with hereditary spastic paraplegia phenotype.
Kufor- Rakeb disease
The disease was first reported in a Jordanian family as 
a syndrome with pallido-pyramidal degeneration, supra 
nuclear upgaze paresis and dementia (21). Mutations 
in ATP13A2 gene, encoding a lysosomal type 5 P-type 
ATPase is known to be responsible for the clinical 
manifestations.
Kufor –Rakeb syndrome is characterized by juvenile 
onset Levodopa_responsive parkinsonism, pyramidal 
tract sign, supra nuclear gaze palsy (accompanied by 
slowing of vertical and horizontal saccads and pursuit 
eye movement), oculogyric dystonic spasm, facial-
faucial-finger myoclonus, visual hallucination and 
dementia.
Brain MRI shows moderate diffuse cerebral and 
cerebellar atrophy. Iron accumulation in caudate and 
Putamen is present in only a portion of patients, and may 
occur late in disease course. Kufor- Rakeb disease is also 
called PARK9 or Parkinson disease 9.
BPAN (Beta- Propeller Protein- Associated 
Neurodegeneration):
Affected individuals show a regression in motor, gait 
(with a dystonia-parkinsonism syndrome) and cognitive 
function in adulthood on a background of global 
developmental delay in childhood and adolescence (22). 
Mutations in WDR45 gene, located on X chromosome 
Xp11-23, are responsible for BPAN disease with a 
distinctive X-linked dominant mode of inheritance. 
This syndrome fulfills the criteria of the unidentified 
syndrome of SENDA (Static Encephalopathy of 
childhood with Neuro Degeneration in Adulthood) and 
probably previous reported cases suffered from BPAN.
SENDA patients have intellectual disability and motor 
delay in infancy and childhood with slow progression in 
motor and intellectual function for one to third decades, 
when a dystonia-parkinsonism degenerative syndrome 
appears in adulthood.
Neuroferritinopathy
Neuroferritinopathy is an autosomal dominant inherited 
disorder (an exception in NBIA) due to mutation in 
FTL gene. Progressive chorea and dystonia appears in 
adulthood with mild cognitive decline. Dystonia starts 
from one limb and evolves into involvement of all limbs 
within 20 years. Orofacial action- specific dystonia is 
specific as well as orolingual dyskinesia (23). Cerebellar 
dysfunction can be seen in some families. Subtle 
dementia is present in most individuals which eventually 
becomes a major problem. Supranuclear gaze palsy may 
appear in some patients and in contrast to many other 
NBIA no ophthalmologic pathology is reported in this 
disease.
Serum ferritin concentration is low in the majority of 
men and post-menopausal women.
 Brain MRI is characteristic for the disease and shows 
cystic changes in the basal ganglia (advanced cases) with 
evidence of brain iron deposition on T2 MRI in globus 
pallidus, putamen, caudate nucleus, substantia nigra and 
red nuclei (24).
Aceruloplasminemia
Aceruloplasminemia is the only NBIA with simultaneous 
iron accumulation in both the brain and viscera. The 
clinical triad of neurologic disease, retinal degeneration 
and diabetes mellitus start in adulthood and older ages. 
Neurologic manifestations include orofacial dystonia 
with blepharospasm and grimacing, dysarthria, chorea, 
tremor and gait ataxia (25). A microcytic hypochromic 
anemia is usually the presenting sign before the onset of 
diabetes mellitus or obvious neurologic sign. 
Aceruloplasminemia is an autosomal recessive disease 
caused by mutation in CP (CeruloPlasmin) gene. 
Ceruloplasmin carries the majority of the plasma copper 
and plays a pivotal role in iron mobilization from tissues. 
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Iron accumulation in brain and viscera is caused by 
ceruloplasmin dysfunction. 
Serum ceruloplasmin is undetectable, serum iron and 
copper is low and in contrast serum ferritin level is 
elevated. 
Abdominal MRI shows abnormal hypointensity in the 
liver and brain MRI iron deposition is confirmed by T1 
and T2 hypointensity in striatum, thalamus and dentate 
nucleus.
CoPAN (COASY  protein-associated  
neurodegeneration)
This newly diagnosed NBIA with autosomal recessive 
mode of inheritance is caused by mutation in COASY 
( CO enzyme A Synthetase) gene (26). The encoding 
protein is a bifunctional enzyme that catalyzes the two 
last steps in Co A synthesis. Biosynthesis of Coenzyme 
A from pantothenic acid (vitamin B5) is an essential 
pathway in human cells.
In the affected patients symptoms began with 
progressive spasticity and dystonia from early 
childhood, followed by dysarthria, oromandibular 
dystonia, parkinsonism and axonal neuropathy. 
Cognitive decline and psychiatric manifestations as 
obsessive compulsive behavior occur in the course of 
the disease. Usually the patients show slow regression 
and have survived into their third decade.
Brain iron deposition in globus pallidus and substantia 
nigra is detected as hypo intensities on T2W images of 
MRI.
Woodhouse-Sakati syndrome
This rare autosomal recessive multi systemic disorder 
consists of hypogonadism, diabetes mellitus alopecia 
mental retardation and extrapyramidal syndrome. A 
founder mutation in C2orf37 gene was reported in 8 
consanguineous family in Saudi Arabia affected by this 
syndrome (27).  
Basal ganglia hypo intensities on T2W brain MRI 
are consistent with iron deposition. White matter 
abnormality is common.
Treatment
Current treatment in NBIA is primarily symptomatic 
for relief of spasticity, dystonia and other movement 
disorder. Commonly used drugs are Benzodiazepines, 
anticholinergic, Baclofen, Neuroleptics and L-dopa 
(especially in parkinsonism).
Deep Brain Stimulation (DBS) causes mild improvement 
in dystonia severity and no definite result has been 
achieved by iron chelating agents (deferiprone for 
example) clinical trials.
Table 1. Types of NBIA: Molecular Genetics
Disease Name Gene  % of NBIA Attributed to Mutations in This Gene Inheritance
PKAN PANK2 35%-50% AR
PLAN PLA2G6 20% AR
MPAN C19orf12 6%-10% AR
BPAN WDR45 1%-2% XLD
FAHN FA2H Rare AR
Kufor-Rakeb syndrome ATP13A2 Rare AR
Neuroferritinopathy FTL Rare AD
Aceruloplasminemia CP Rare AR
Woodhouse-Sakati syndrome DCAF17 Rare AR
CoPAN COASY Rare AR
PKAN= Pantothenate Kinase-associated Neurodegeneration
PLAN= PLA2G6-associated neurodegeneration
MPAN= Mitochondrial Membrane Protein-Associated 
Neurodegeneration
BPAN = Beta-Propeller Protein-Associated Neurodegeneration
FAHN = Fatty Acid Hydroxylase-Associated Neurodegeneration
CoPAN = Coasy Protein-Associated Neurodegeneration
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Fig 1. A 12 year-old boy with progressive dystonia-Parkinsonism & cognitive decline since early childhood (a, b): 
SWI sequence which is tailored to detect Iron deposition represents signal void Iron in the Substantial Nigra & Brain 
Stem (white arrows) apparently which is not detectable in other sequences. (c): Signal void abnormality as black 
part in SWI sequenc  in the bilateral BG confirming Iro  deposition disorder (yellow arrow). (d): This is Axial T2W 
seque ce and represents reduced signal due to Iron deposition i  Substantial Nigra which is not well detectable. 
(Yellow arrows). (e): Pre and post contrast T1W represent no abnormal enhancement. No define finding related to 
Iron deposition is seen in the sequence. (f 1&2): In the Flair sequence there is signal void appearance and reduced 
signal pattern in Globus Pallidus (f1) which may be missed easily: in this sequence Iron deposition in the Substantial 
Nigra is not detectable (f2).
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